Physician profile
George A Abboud
NPI 1104880475
$3,629.89
in general payments reported to CMS, 2019-2025
22 companies · $262 in 2025
The $262 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $584 · 2020: $325 · 2022: $44.19 · 2023: $462 · 2024: $1,952 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,500 · Food and Beverage: $1,176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,500.00 |
| Food and Beverage | $1,176.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avita Medical Americas, LLC | $1,500.00 | 2024 | |
| Medshape, INC. | $562.46 | 2023-2024 | Dynaclip Bone Fixation System, Quattro, 22mm X 20mm X 20mm, Dynanail Helix, Washer, 15 Mm |
| Horizon Therapeutics Plc | $334.37 | 2019-2022 | |
| Organogenesis INC. | $204.69 | 2019-2024 | Puraply |
| Wright Medical Technology, INC. | $172.73 | 2019-2020 | |
| Trilliant Surgical LLC. | $131.54 | 2019 | |
| Amgen INC. | $120.41 | 2025 | Krystexxa |
| Djo, LLC | $108.63 | 2019-2025 | Cmf |
| Smith+Nephew, INC. | $97.31 | 2019-2023 | Regranex, Collagenase Santyl, Pico 7 |
| Bone Support INC. | $85.78 | 2020 | |
| Averitas Pharma INC. | $49.97 | 2023 | Qutenza |
| Paratek Pharmaceuticals, INC. | $38.59 | 2020-2025 | Nuzyra |
| Axogen | $37.92 | 2019 | |
| Stryker Corporation | $35.92 | 2019 | |
| Boston Scientific Corporation | $31.26 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $23.04 | 2023 | Physio-Stim |
| Alfasigma USA, INC. | $21.04 | 2020 | |
| Acumed LLC | $19.37 | 2020 | |
| Depuy Synthes Sales INC. | $15.08 | 2025 | Healix Knotless Peek, Quickanchor Orthocord |
| Ani Pharmaceuticals, INC. | $15.02 | 2025 | Purified Cortrophin Gel |
| Merck Sharp & Dohme LLC | $12.57 | 2019 | |
| Bioventus LLC | $12.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Abboud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.